Related Experiment Videos
Loperamide Induced Life Threatening Ventricular Arrhythmia
Ankit Upadhyay1, Vijaykumar Bodar1, Mohammad Malekzadegan1
1Jamaica Hospital Medical Center, Department of Medicine, Jamaica, NY 11418, USA.
Loperamide abuse can lead to severe cardiac events, including fatal arrhythmias. This case highlights the risk of Loperamide toxicity causing QTc prolongation and cardiac arrest, even in individuals with underlying conditions.
Area of Science:
- Cardiology
- Clinical Toxicology
- Pharmacology
Background:
- Loperamide, an over-the-counter antidiarrheal, acts on peripheral μ opioid receptors.
- Increasing Loperamide abuse is noted, with individuals using it as an opioid substitute.
- High doses of Loperamide can lead to serious adverse effects.
Purpose of the Study:
- To report a case of cardiac arrest following excessive Loperamide consumption.
- To investigate the potential causal link between Loperamide toxicity and cardiac events.
- To raise awareness regarding the risks of Loperamide abuse.
Main Methods:
- Case report of a 46-year-old male presenting with cardiac arrest.
- Exclusion of other potential causes of cardiac arrest, including ischemia, cardiomyopathy, and sepsis.
- Analysis of patient's Loperamide usage history and cardiac monitoring (QTc interval).
Main Results:
- The patient consumed up to 200 mg of Loperamide daily for two days prior to cardiac arrest.
- Loperamide toxicity was hypothesized as the cause of QTc prolongation and cardiac arrest.
- Gradual resolution of tachyarrhythmia and QTc interval decrease observed during hospitalization.
Conclusions:
- Loperamide overdose can cause QTc prolongation and potentially fatal arrhythmias.
- The case suggests Loperamide may unmask underlying congenital long QT syndrome.
- This case underscores the existence of Loperamide overdose-related cardiac toxicity and the need to address its abuse.
Related Concept Videos
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Drugs for Treatment of Constipation-Predominant IBS
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists